Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress
Diagnostics · 29.10.2024 · 14 (21) · 2406
DOI: 10.3390/diagnostics14212406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 29.10.2024. Verfasst von Srdjan Nikolovski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL 60153, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, the Republic of Serbia.
Abstract (Originalsprache)
Background/Objectives: Besides a multitude of consequences patients on chronic renal replacement therapy have, anemia is one of the most prominent factors making a significant number of patients dependent on erythropoiesis-stimulating agent (ESA) therapy. The aim of this study was to examine the relationship between the levels of a broad spectrum of thrombo-inflammatory and oxidative stress-related biomarkers and the presence and level of ESA hyporesponsiveness in patients undergoing regular chronic hemodialysis.
Methods
This cross-sectional study included 96 patients treated with chronic hemodialysis. Levels of several thrombo-inflammatory and oxidative stress-related biomarkers, as well as demographic, clinical, and laboratory analyses, were collected and analyzed based on the calculated value of the ESA-hyporesponsiveness index (EHRI).
Results
In the analyzed sample, 58 patients received ESAs. Of all the investigated parameters, only body mass index (BMI), level of plasminogen activator inhibitor-1, and level of L-type fatty acid binding protein (L-FABP) were observed as significant predictors of EHRI. A significant diagnostic potential for ESA resistance has been observed in BMI and L-FABP between ESA-resistant and ESA-non-resistant groups of patients (p = 0.004, area under the curve 0.763 and p = 0.014, area under the curve 0.712, respectively) with the cut-off values of 25.46 kg/m2 and 5355.24 ng/mL, respectively. Having a BMI of 25.46 kg/m2 or less and an L-FABP level higher than 5355.24 ng/mL were observed as significant predictors of ESA resistance (odds ratio 9.857 and 6.125, respectively).
Conclusions
EHRI was positively predicted by low BMI and high levels of plasminogen activator inhibitor-1 and L-FABP. High levels of L-FABP and low BMI have been observed as strong predictors of ESA resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.
- Institute for Pharmacology, Clinical Pharmacology and Toxicology, University of Belgrade School of Medicine, 11000 Belgrade, Serbia.
- Institute for Microbiology and Immunology, University of Belgrade School of Medicine, 11000 Belgrade, Serbia.
- Eye Institute "Knezovic", 10000 Zagreb, Croatia.
- DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Harrogate, TN 37752, USA.
- Department of Molecular Pharmacology and Neuroscience, Loyola University Medical Center, Maywood, IL 60153, USA.
ORCID-Profile: Srdjan Nikolovski, Branislava Medic Brkic, Ivana Cirkovic, Nina Jovanovic, Omer Iqbal, Chongyu Zhang
Förderung
- Ministry of Science, Technological Development and Innovation, the Republic of Serbia
Zitieren
APA
Nikolovski, S., Medic Brkic, B., Vujovic, K. S., Cirkovic, I., Jovanovic, N., Reddy, B., Iqbal, O., Zhang, C., Fareed, J., & Bansal, V. (2024). Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress. Diagnostics, 14(21), 2406. https://doi.org/10.3390/diagnostics14212406
Vancouver
Nikolovski S, Medic Brkic B, Vujovic KS, Cirkovic I, Jovanovic N, Reddy B, et al. Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress. Diagnostics. 2024;14(21):2406. doi:10.3390/diagnostics14212406
BibTeX
@article{Nikolovski2024,
author = {Nikolovski, Srdjan and Medic Brkic, Branislava and Vujovic, Katarina Savic and Cirkovic, Ivana and Jovanovic, Nina and Reddy, Bhavana and Iqbal, Omer and Zhang, Chongyu and Fareed, Jawed and Bansal, Vinod},
title = {Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {21},
pages = {2406},
doi = {10.3390/diagnostics14212406}
}
EUVIMED